Secura Bio to Participate in the 2025 Jefferies Global Healthcare Conference in London

BERKELEY HEIGHTS, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc. (www.securabio.com), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced that Chip Romp, Chief Executive Officer, and Will Brown, Chief Financial Officer will participate in upcoming Jefferies Global Healthcare Conference taking place from November 17 to 20, 2025 in London, UK.

If you would like to request a meeting with company management, please contact ir@securabio.com.

About Secura Bio, Inc.
Secura Bio is an integrated, commercial-stage pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies for physicians and their patients. For more information on Secura Bio, please visit https://www.securabio.com/.

Investor Contact
Will Brown
Chief Financial Officer
Phone: 619-986-1364
ir@securabio.com

Media Contact
Kit Rodophele
Ten Bridge Communications
Phone: 617-999-9620
krodophele@tenbridgecommunications.com


MORE ON THIS TOPIC